Panilagan, Samuel E.

HRN: 12-62-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/23/2026
06/30/2026
IV
4.5 Gm
Q8h
For “E” Exploratory Laparotomy
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: